yweigel@cooley.com
Yuri Weigel practices corporate law, with a focus on representing emerging and public companies, including venture capital financings, public offerings and mergers and acquisitions.
Download full bio
Rodeo Therapeutics Agrees to Sell to Amgen for $721 Million
ConvergeOne Announces $1.2 Billion Combination With Forum Merger to Become Public Company
Alder Biopharmaceuticals $80 Million Initial Public Offering
Emerging Companies
Venture Capital
George Washington University Law SchoolJD, With highest honors, Order of the Coif, 2013
University of WashingtonBA, Comparative History of Ideasmagna cum laude, 2007
Washington
World View Closes Series C to Reach Edge of Space June 12, 2018
ConvergeOne Announces $1.2 Billion Combination With Forum Merger to Become Public Company December 19, 2017
World View Closes Series B Financing to Develop High-Altitude Balloons May 5, 2016
View all
+1 206 452 8831
Locations